Invention Grant
US09271988B2 Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer
有权
包含用于治疗癌症的CDK4 / 6抑制剂和P13K抑制剂的组合疗法
- Patent Title: Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer
- Patent Title (中): 包含用于治疗癌症的CDK4 / 6抑制剂和P13K抑制剂的组合疗法
-
Application No.: US14124753Application Date: 2012-07-02
-
Publication No.: US09271988B2Publication Date: 2016-03-01
- Inventor: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
- Applicant: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Jennifer C Chapman
- International Application: PCT/US2012/045199 WO 20120702
- International Announcement: WO2013/006532 WO 20130110
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/5377 ; C07D487/02 ; A61K31/4439 ; A61K45/06
Abstract:
A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
Public/Granted literature
Information query
IPC分类:
